Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03476174
Title Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ralph Hauke



Aldesleukin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Nebraska Cancer Specialists Omaha Nebraska 68114 United States Details
*Shaded cells indicate that there was no data available from for the field